AUD 0.02
(-5.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | -4.36 Million AUD | 56.55% |
2023 | -10.03 Million AUD | -23.83% |
2022 | -8.1 Million AUD | -31.24% |
2021 | -6.17 Million AUD | -72.41% |
2020 | -3.58 Million AUD | 34.94% |
2019 | -5.5 Million AUD | 16.5% |
2018 | -6.59 Million AUD | 11.97% |
2017 | -7.49 Million AUD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q4 | -1.86 Million AUD | 49.76% |
2024 FY | -7.16 Million AUD | 28.67% |
2024 Q2 | -3.71 Million AUD | 20.24% |
2023 Q4 | -4.65 Million AUD | 13.46% |
2023 Q2 | -5.38 Million AUD | -52.32% |
2023 FY | -10.03 Million AUD | -23.83% |
2022 Q2 | -4.57 Million AUD | -15.25% |
2022 FY | -8.1 Million AUD | -31.24% |
2022 Q4 | -3.53 Million AUD | 22.75% |
2021 Q2 | -2.2 Million AUD | -192.29% |
2021 FY | -6.17 Million AUD | -72.41% |
2021 Q4 | -3.96 Million AUD | -79.69% |
2020 FY | -3.58 Million AUD | 34.94% |
2020 Q4 | -755.64 Thousand AUD | 62.6% |
2020 Q2 | -2.02 Million AUD | -15.25% |
2019 FY | -5.5 Million AUD | 16.5% |
2019 Q4 | -1.75 Million AUD | 31.54% |
2019 Q2 | -2.56 Million AUD | 0.0% |
2018 FY | -6.59 Million AUD | 11.97% |
2017 FY | -7.49 Million AUD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
4DMedical Limited | -27.96 Million AUD | 84.405% |
Adherium Limited | -11.98 Million AUD | 63.61% |
Aroa Biosurgery Limited | -9.78 Million AUD | 55.439% |
Anteris Technologies Ltd | -66.63 Million AUD | 93.454% |
Control Bionics Limited | -5.92 Million AUD | 26.442% |
CardieX Limited | -4.63 Million AUD | 5.875% |
Compumedics Limited | -269 Thousand AUD | -1521.367% |
Cochlear Limited | 521.5 Million AUD | 100.836% |
CleanSpace Holdings Limited | -4.81 Million AUD | 9.399% |
Cyclopharm Limited | -9.22 Million AUD | 52.719% |
EMVision Medical Devices Ltd | -1.61 Million AUD | -170.159% |
Nova Eye Medical Limited | -3.79 Million AUD | -14.866% |
HeraMED Limited | -6.42 Million AUD | 32.149% |
Imricor Medical Systems, Inc. | -17.57 Million AUD | 75.184% |
ImpediMed Limited | -19.03 Million AUD | 77.088% |
InhaleRx Limited | -1.38 Million AUD | -214.57% |
LBT Innovations Limited | -4.74 Million AUD | 7.986% |
Micro-X Limited | -13.02 Million AUD | 66.52% |
Neurotech International Limited | -5.58 Million AUD | 21.904% |
OncoSil Medical Limited | -11.98 Million AUD | 63.606% |
PolyNovo Limited | 1.16 Million AUD | 475.02% |
Respiri Limited | -7 Million AUD | 37.695% |
SomnoMed Limited | -3.84 Million AUD | -13.542% |
Universal Biosensors, Inc. | -16.68 Million AUD | 73.853% |
Uscom Limited | -2.4 Million AUD | -81.4% |
Visioneering Technologies, Inc. | -5.85 Million AUD | 25.497% |